Annexon (ANNX) Net Cash Flow (2019 - 2026)
Annexon's (ANNX) quarterly Net Cash Flow came in at $13.2 million in Q1 2026, down 72.38% year-on-year from $47.6 million in Q1 2025, and down 41.87% quarter-over-quarter from $22.6 million in Q4 2025.
Annexon (ANNX) Net Cash Flow (2019 - 2026) Analysis & Trends
Annexon's Net Cash Flow history runs 8 years deep, the most recent figure standing at $13.2 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 72.38% year-over-year to $13.2 million in Q1 2026; TTM through Mar 2026 was $78.1 million, a 242.45% increase from a year earlier, with the FY2025 full-year figure at $112.6 million, up 164.1% from the prior year.
- Net Cash Flow slipped to $13.2 million in Q1 2026 per ANNX's latest filing, from $22.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $106.0 million in Q3 2022 and bottomed at -$77.8 million in Q3 2024.
- The 5-year median for Net Cash Flow is $7.1 million (2025), against an average of $5.9 million.
- Across the five-year window, Net Cash Flow tumbled 1882.14% in 2024 and jumped 555.8% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at -$70.6 million in 2022, then surged by 230.14% to $91.9 million in 2023, then tumbled by 132.67% to -$30.0 million in 2024, then jumped by 175.35% to $22.6 million in 2025, then plunged by 41.87% to $13.2 million in 2026.
- Per Business Quant, the three latest ANNX Net Cash Flow figures stand at $13.2 million (Q1 2026), $22.6 million (Q4 2025), and $7.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 224.46 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | 13.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.16 Mn |
| Mar 31, 2026 | 13.16 Mn |
| Dec 31, 2025 | 22.63 Mn |
| Dec 31, 2025 | 22.63 Mn |
| Sep 30, 2025 | 7.13 Mn |
| Sep 30, 2025 | 7.13 Mn |
| Jun 30, 2025 | 35.16 Mn |
| Jun 30, 2025 | 35.16 Mn |
| Mar 31, 2025 | 47.62 Mn |
| Mar 31, 2025 | 47.62 Mn |
| Dec 31, 2024 | -30.04 Mn |
| Dec 31, 2024 | -30.04 Mn |
| Sep 30, 2024 | -77.77 Mn |
| Sep 30, 2024 | -77.77 Mn |
| Jun 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.36 Mn |
| Mar 31, 2024 | -73.16 Mn |
| Mar 31, 2024 | -73.16 Mn |
| Dec 31, 2023 | 91.94 Mn |
| Dec 31, 2023 | 91.94 Mn |